Search

Your search keyword '"Soucy, Jean‐Paul"' showing total 304 results

Search Constraints

Start Over You searched for: Author "Soucy, Jean‐Paul" Remove constraint Author: "Soucy, Jean‐Paul" Search Limiters Full Text Remove constraint Search Limiters: Full Text
304 results on '"Soucy, Jean‐Paul"'

Search Results

1. Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease

2. Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease

3. Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology

4. The neurophysiological brain-fingerprint of Parkinson’s disease

7. Amyloid-PET of the white matter: Relationship to free water, fiber integrity, and cognition in patients with dementia and small vessel disease

9. Author Correction: [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease

10. [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease

12. Evaluation of an automated feedback intervention to improve antibiotic prescribing among primary care physicians (OPEN Stewardship): a multinational controlled interrupted time-series study

13. An Evaluation of the Impact of an OPEN Stewardship Generated Feedback Intervention on Antibiotic Prescribing among Primary Care Veterinarians in Canada and Israel

14. Microglial activation and tau propagate jointly across Braak stages

17. Distinct spatial contributions of amyloid pathology and cerebral small vessel disease to hippocampal morphology.

18. Structural white matter properties and cognitive resilience to tau pathology.

19. Public transit mobility as a leading indicator of COVID-19 transmission in 40 cities during the first wave of the pandemic.

20. Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease

21. Ecart de mobilite: estimation des seuils de mobilite requis pour maitriser le SRAS-CoV-2 au Canada

24. The Consortium for the early identification of Alzheimer's disease–Quebec (CIMA-Q)

25. The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada

27. Publisher Correction: Microglial activation and tau propagate jointly across Braak stages

28. Bayesian workflow for the investigation of hierarchical classification models from tau-PET and structural MRI data across the Alzheimer’s disease spectrum

29. Amyloid beta plaque accumulation with longitudinal [18F]AZD4694 PET

30. EFFECTS OF VASCULAR BURDEN ON COGNITION ARE MEDIATED BY ATROPHY, AMYLOID, AND GLUCOSE METABOLISM: A MULTI-CENTRE MIXED COHORT OF SMALL VESSEL DISEASE AND ALZHEIMER'S PATHOLOGY

32. APOE ε4 associates with microglial activation independently of Aβ plaques and tau tangles

34. Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis

35. Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer’s disease

37. Dosimetry of [18F]TRACK, the first PET tracer for imaging of TrkB/C receptors in humans.

38. The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [18F]MK6240 Tau PET in Target Regions

39. sj-pdf-1-jcb-10.1177_0271678X231152001 - Supplemental material for Amyloid-PET of the white matter: Relationship to free water, fiber integrity, and cognition in patients with dementia and small vessel disease

40. In vivo quantification of neurofibrillary tangles with [18F]MK-6240

43. Mapping neurotransmitter systems to the structural and functional organization of the human neocortex

46. Geriatric dementia care at Ontario Shores: A new model of care

49. 18F-MK-6240 tau-PET in genetic frontotemporal dementia

50. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages

Catalog

Books, media, physical & digital resources